2024-2025 Society Incoming Leadership
Thank you to all SSO members who submitted nominations for their colleagues to serve in leadership roles! Joining the current SSO Officers and Executive Council members, the following individuals will be formally inducted at the SSO 2024 Annual Business Meeting in March.
Executive Council Members
Vice President (2024-2027)
Margo Shoup, MD, MBA, FSSO
Dr. Margo Shoup completed a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center in 2002, and joined Loyola University Medical Center where she became Professor and Vice Chair of Surgery and Assistant Dean of the Medical School. Since then, she completed an MBA at University of Massachusetts in Amherst, has taken executive leadership roles at community, community teaching, and integrated healthcare systems and has been an advocate for bringing high quality surgical oncology care to community settings. Dr. Shoup served as a Director of the American Board of Surgery, where she sat on the Complex General Surgical Oncology Board and participated in the development of the inaugural written and oral exams. She has had leadership roles in several surgical societies, including being the immediate Past -President of the Western Surgical Association. She has participated in and led many initiatives with the Society of Surgical Oncology, having served on the Executive Council as the community surgeon representative, and currently serving as the co-Chair of the Women in Cancer Surgery group. Margo lives in Orlando, Florida, has been married for 33 years and is the proud mother of two grown children. She enjoys traveling, hiking, golf and live music.
Executive Council Member (2024-2027)
Ryan Fields, MD, FACS
Dr. Fields is a surgical oncologist and translational scientist who treats solid tumors, including pancreatic cancer, primary and metastatic liver cancers, gastric cancer, soft tissue sarcoma, and melanoma. His research training began at the University of Michigan under the mentorship of Drs. James Mulé and Alfred Chang in tumor immunology. These early studies of dendritic cell-based cancer vaccines set the stage for his interest in cancer biology and immunology. Since that time, Dr. Fields has continued his research and clinical training in surgical oncology and solid tumor biology and immunology. He completed a Surgical Oncology Fellowship at Memorial Sloan-Kettering Cancer Center. He also has >300 peer-reviewed publications with an emphasis on solid tumor biology, treatment, and outcomes. Dr. Fields is the Chief of Surgical Oncology and serves as the Director of the Washington University Solid Tumor Tissue Bank and Registry. He is also the Co-Leader of the Solid Tumor Therapeutics Program (STTP) and the Melanoma and Cutaneous Oncology Program at the Alvin J. Siteman NCI-designated Comprehensive Cancer Center at Washington University School of Medicine in St. Louis, Missouri.
Executive Council Member (2024-2027)
E. Shelley Hwang, MD, MPH, FSSO
Dr. Shelley Hwang, MD, MPH is the Mary and Deryl Hart Professor of Surgical Oncology, Vice Chair of Research in the Department of Surgery, and Director of the Breast Oncology Program for the Duke University Comprehensive Cancer Center. Her research focus includes breast cancer prevention, identifying less invasive treatments for early-stage breast cancers and understanding the genetic and stromal determinants of cancer progression as a PI of the Breast Precancer Center in the Human Tumor Atlas Network. She is a member of the ASA, ASCO, and ACS CoC, fellow of the SSO, and Co-Chairs the NCI Breast Cancer Steering Committee.
International Representative to the Executive Council (2024-2027)
Julie Hallet, MD, MSc, FRCSC, FSSO
Dr. Hallet is an Associate Professor of Surgery at the University of Toronto and a Surgical Oncologist with a clinical practice devoted to hepato-biliary, pancreatic and upper gastrointestinal malignancies at the Odette Cancer Centre – Sunnybrook Health Sciences Centre. Her practice further focuses on neuroendocrine tumors as part of the Susan Leslie Multidisciplinary Clinic for Neuroendocrine Tumors. She completed her medical degree, general surgery residency, and MSc in clinical epidemiology at Université Laval in Québec City. This was followed by a clinical fellowship in Complex Surgical Oncology and Hepato-Pancreato-Biliary surgery at the University of Toronto, and additional training in advanced minimally invasive surgery at IRCAD in Strasbourg, France.
As a surgeon-investigator, Dr. Hallet’s leads a research program in health services research to examine the delivery of quality patient-centered and sustainable cancer care. This work has obtained over $10 millions in peer-reviewed funding and led to more than 200 peer-reviewed publications.
Mediget Teshome, MD, MPH, FACS
Mediget Teshome MD, MPH, FACS is currently an Associate Professor of Clinical Surgery, Section Chief of Breast Surgery and Director of Breast Health at the University of California Los Angeles (UCLA) within the Department of Surgery, Division of Surgical Oncology. She is committed to advancing the care of women and men with breast cancer through high quality patient care, collaborative clinical research, education, career development, and promoting equity in health care and society.
Dr. Teshome received her undergraduate education at UCLA and Medical Degree at the University of Michigan Medical School. She graduated from the Stanford General Surgery Residency Program during which she also obtained an MPH degree from the Harvard School of Public Health. She then completed a Breast Surgical Oncology Fellowship at the University of Texas M.D. Anderson Cancer Center, where she joined the faculty until transitioning to UCLA in January 2024.
As a faculty member at MD Anderson, Dr. Teshome served in several leadership roles including the Program Director for the Breast Surgical Oncology Fellowship Program, Division of Surgery Professionalism Ambassador, Faculty Senator for the Department of Breast Surgical Oncology and Chair of the Mid-Career Faculty Committee.
Nominating Committee Members
International Representative (2024-2026)
Rodrigo Nascimento Pinheiro, MD, MSc
Rodrigo Nascimento Pinheiro, MD, MSc, PhD, a surgical oncologist at the Surgical Oncology Service of the Federal District, Hospital de Base, Brasília, Brazil, was trained at the Brazilian National Cancer Institute, Rio de Janeiro, Brazil. Dr. Pinheiro has a master’s degree and Ph.D. in Sciences from Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil, and has experience in managing public and private health systems in Brazil.
Dr. Pinheiro is currently President (2023-2025) of the Brazilian Society of Surgical Oncology, BSSO, where he also held the positions of Director of Professional Defense (2019-2021) and Vice President (2021-2023) and also serves as a member of the Technical Chamber in Surgical Oncology from the Federal Council of Medicine and the Oncology Advisory Council of the Brazilian Ministry of Health, assisting in the construction of public policies and the regulation of medicine in Brazil. He actively carries out teaching and research activities, is the author of books and scientific articles, and is a member of the commission for the Brazilian Title of Specialist in Surgical Oncology and supervisor of a medical residency in surgical oncology.
Also, as a fellow of the Brazilian College of Surgeons and a member of the ESSO and SSO, Dr. Pinheiro is an enthusiast for building plural and global solutions to reduce inequalities and disparities in cancer treatment worldwide, actively participating in the Global Forum of Cancer Surgeons.
Community Practice Representative (2024-2026)
Natasha Rueth, MD, MS, FACS
Dr. Natasha M. Rueth is a board-certified surgical oncologist with a professional interest and specialization in breast cancer. She completed her general surgery residency at the University of Minnesota, earning a 2-year master’s degree in clinical research. She completed her CGSO fellowship at MD Anderson Cancer Center in 2014. Dr. Rueth is currently employed at Allina Health Cancer Institute serving as medical director, overseeing multidisciplinary cancer care for a busy community cancer center. She has successfully led a group of general surgeons, surgical oncologists, and breast surgeons providing care in a large system consisting of three major metropolitan multidisciplinary clinical settings.
Dr. Rueth’s leadership has focused on personal development and her local organization. Skilled at interpersonal communication and maintaining relationships, she has maintained a network of professional peers that span multiple organizations, disciplines, geographies, and practice styles. She regularly connects with her peers to discuss practice approaches, training opportunities, to support fellow trainees, recruit peers, and maintain professional contacts.
One of Dr. Rueth’s particular passions is working to expand breast health to underserved populations. Within her own organization she serves as one of the original members and physician champions of the breast health and diversity committee, which is led by a tremendously passionate member of the breast imaging department. This group has been instrumental in advancing imaging standards for transgender individuals, working to translate educational materials into the native language of our community members to facilitate medical literacy, and hosting DEI&B lectures.
Undesignated Active Member (2024-2026)
Lesly Dossett, MD, MPH
Lesly Dossett, MD, MPH is Associate Professor and Chief of the Division of Surgical Oncology at the University of Michigan. Dr. Dossett completed medical school and general surgery residency at Vanderbilt University Medical Center. During a research fellowship, she was awarded an Agency for Healthcare Research and Quality (AHRQ) T32 and obtained an MPH focused on the study of healthcare delivery. After residency, she served for four years in the United States Navy as an active-duty surgeon in multiple operational and combat support roles stateside and overseas. After completing her Navy service, she completed a complex general surgical oncology fellowship at Moffitt Cancer Center. She joined the faculty at the University of Michigan in 2016. In her clinical practice, she treats patients with intraabdominal and retroperitoneal sarcoma, melanoma, and breast cancer.
Dr. Dossett has made significant contributions to the field of surgical oncology through research. She is an AHRQ and NCI R01-funded investigator on the topics of cancer quality and healthcare delivery. Dr. Dossett has a strong history of membership and engagement in the SSO. She has been a member of the society since 2013, a regular attendee at the annual meeting, and an active participant in SSO-sponsored education events. Dr. Dossett has served the SSO as a member of the Quality Committee, Diversity Equity and Inclusion Committee, the Sarcoma Disease Site Working Group, and the CME Committee. While on the Quality Committee, she served as the SSO representative to the ACS Surgical Quality Alliance. Dr. Dossett is a regular contributor to the Annals of Surgical Oncology and is currently a member of the Editorial Board. Beyond her commitment to the SSO, she has a history of inclusive and effective leadership at the national society level and has the skills and experience to help lead the organization toward its new strategic priorities.
Questions about the nominations process or eligibility requirements? Contact Andrea King, Director, Governance & Operations at firstname.lastname@example.org.